Brevan Howard Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$77.1K	Buy	78,715 +45,782	+139%	+$44.9K	﹤0.01%	1708
2025 Q1	$47.4K	Buy	+32,933	New	+$47.4K	﹤0.01%	1046
2024 Q2	–	Sell	-69,025	Closed	-$185K	–	1095
2024 Q1	$185K	Buy	+69,025	New	+$185K	﹤0.01%	767